Are ongoing trials on hematologic malignancies still excluding older subjects? - Wikidata - wikimedia - TriplyDB

Are ongoing trials on hematologic malignancies still excluding older subjects?

Are ongoing trials on hematologic malignancies still excluding older subjects?

http://www.wikidata.org/entity/Q43111401

about

Multiple myeloma in the older adult: better prospects, more challenges.Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.Optimizing quality of life in multiple myeloma patients: current options, challenges and recommendations.Nuances in the Management of Older People With Multiple Myeloma.Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries.Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas.Frailty in Hematologic Malignancy.

P2860

Q34031129-AAFCD2C5-D992-4C12-A45E-0B825CA5E5F7 Q36107268-C93922B5-5205-424C-8962-E0DC6013A0D2 Q38367654-D15D6692-031A-4D79-97C1-0210557BC14D Q38796491-8315040D-3162-43ED-8416-005EAA7124CD Q48206720-432A0A01-F513-4107-A35A-920EA068B4D7 Q52717111-87CF158C-2C7D-4CC6-8C59-BE4E95CCB1C6 Q55360943-E98F40D8-193B-48BA-960F-11192E8D1D79

P2860

Are ongoing trials on hematologic malignancies still excluding older subjects?

http://www.wikidata.org/entity/Q43111401

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Are ongoing trials on hematologic malignancies still excluding older subjects?

@en

Are ongoing trials on hematologic malignancies still excluding older subjects?

@nl

type

label

Are ongoing trials on hematologic malignancies still excluding older subjects?

@en

Are ongoing trials on hematologic malignancies still excluding older subjects?

@nl

prefLabel

Are ongoing trials on hematologic malignancies still excluding older subjects?

@en

Are ongoing trials on hematologic malignancies still excluding older subjects?

@nl

P1433

Q43111401-760E5961-EC53-4A21-A396-16B537C2AC2C

P1476

Q43111401-7BE67F8E-E8AC-4E0F-BA29-E1EA8364A212

P2093

Q43111401-0B87B855-A21B-4DE0-BB99-470FC9FB3558

Q43111401-7731DA10-0900-4562-AE32-5CE33E63C677

Q43111401-B3F2A59B-BB72-4BE6-89F9-53A7218E3D27

Q43111401-C351C376-A076-41F3-AF6F-D134485E0D70

Q43111401-D2890E18-DA1B-454C-9638-325814E781A0

Q43111401-DA080E57-863C-4EC2-B6D2-45DBFAD35EF0

P2860

Q43111401-10AD18E8-6FCE-4625-8BA2-A49CFDBBC2B5

Q43111401-2ACC0625-F266-415A-803E-E5B43D5A45C9

Q43111401-3303860A-5D80-44C9-A499-F80FCCE97F83

Q43111401-377C8485-4512-4EBA-86EE-66FFE05E0AAD

Q43111401-4FDBFB41-7876-415C-90FE-2EC2CB38FB91

Q43111401-69A29907-1EE8-4241-B72F-30B7572A6E1D

Q43111401-74FE4D23-0AB9-4A70-B7C3-E8F5CD8FD65C

Q43111401-75BBF338-D8FC-423D-AC8D-3A194B4FE5A4

Q43111401-7997B382-C12C-46E0-B54F-B1D7B0E7B9CC

Q43111401-80DB9964-180F-476C-A7E4-63B9859F468A

P304

Q43111401-B7B84F11-AB35-4D0F-A35D-E1D358A211A2

P31

Q43111401-3fab1bd1-db99-4d0c-a5f3-bc294fd0212e

Q43111401-AEB78E29-34AB-4634-9525-91C602E684AA

P356

Q43111401-4F77C6ED-3BB5-4BF3-9DB8-D5F1BBE91128

P433

Q43111401-68B49B36-5747-4233-A4EA-F51BCB4364F1

P478

Q43111401-CA6FE1D7-6DD8-4E29-ADEE-A0526E9CC480

P50

Q43111401-31EC60C8-0576-4454-8CA0-C33AE99FE383

Q43111401-EB9C4857-0A7A-416F-A913-0079FECD473B

P577

Q43111401-D5DD3827-B2D5-41BB-9235-8E9E096D3F30

P698

Q43111401-140DCFD6-BEBD-42A0-ADDE-3E3DFB4ADE39

P932

Q43111401-E19F50FE-0983-47E8-90E6-74C0C8DC3574

P356

HAEMATOL.2013.087601

P1433

P1476

Are ongoing trials on hematologic malignancies still excluding older subjects?

@en

P2093

Annarita Cerenzia

http://www.w3.org/2001/XMLSchema#string

Beatrice Gasperini

http://www.w3.org/2001/XMLSchema#string

Elisabetta Bonifacio

http://www.w3.org/2001/XMLSchema#string

Fabrizia Lattanzio

http://www.w3.org/2001/XMLSchema#string

Flavio Falcinelli

http://www.w3.org/2001/XMLSchema#string

Francesca Pierri

http://www.w3.org/2001/XMLSchema#string

P2860

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

Multiple myeloma in elderly patients: presenting features and outcome.

Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials.

Older female cancer patients: importance, causes, and consequences of undertreatment.

Epidemiology of chronic myeloid leukaemia (CML).

The epidemiology of myelodysplastic syndromes.

Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).

Improved survival among younger but not among older patients with Multiple Myeloma in the Netherlands, a population-based study since 1989.

Cancer rates, medical comorbidities, and treatment modalities in the oldest patients.

Recent major improvement in long-term survival of younger patients with multiple myeloma.

P304

997-1000

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2013.087601

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Cherubini

Elisa Zengarini

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23813644

http://www.w3.org/2001/XMLSchema#string

P932

3696593

http://www.w3.org/2001/XMLSchema#string